BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34054926)

  • 1. Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy.
    Tan Z; Wu L; Fang Y; Chen P; Wan R; Shen Y; Hu J; Jiang Z; Hong K
    Front Genet; 2021; 12():670787. PubMed ID: 34054926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the crucial mitochondrial DNA in hypertrophic cardiomyopathy prognosis and diagnosis: A review.
    Liao X; Zhou S; Zeng D; Ying W; Lian D; Zhang M; Ge J; Chen M; Liu Y; Lin Y
    Medicine (Baltimore); 2023 Dec; 102(48):e36368. PubMed ID: 38050313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic identification and analysis of dysregulated miRNA and transcription factor feed-forward loops in hypertrophic cardiomyopathy.
    Shi H; Li J; Song Q; Cheng L; Sun H; Fan W; Li J; Wang Z; Zhang G
    J Cell Mol Med; 2019 Jan; 23(1):306-316. PubMed ID: 30338905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy.
    Sasagawa S; Nishimura Y; Okabe S; Murakami S; Ashikawa Y; Yuge M; Kawaguchi K; Kawase R; Okamoto R; Ito M; Tanaka T
    Front Pharmacol; 2016; 7():162. PubMed ID: 27378925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
    Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
    J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Analysis of Cardiac Hypertrophic Growth in
    Farrell E; Armstrong AE; Grimes AC; Naya FJ; de Lange WJ; Ralphe JC
    Front Physiol; 2018; 9():1442. PubMed ID: 30410445
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioinformatics analysis of the regulatory lncRNA‑miRNA‑mRNA network and drug prediction in patients with hypertrophic cardiomyopathy.
    Li J; Wu Z; Zheng D; Sun Y; Wang S; Yan Y
    Mol Med Rep; 2019 Jul; 20(1):549-558. PubMed ID: 31180540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
    Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
    Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes.
    Lim DS; Roberts R; Marian AJ
    J Am Coll Cardiol; 2001 Oct; 38(4):1175-80. PubMed ID: 11583900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.
    Liu Y; Afzal J; Vakrou S; Greenland GV; Talbot CC; Hebl VB; Guan Y; Karmali R; Tardiff JC; Leinwand LA; Olgin JE; Das S; Fukunaga R; Abraham MR
    Front Cardiovasc Med; 2019; 6():170. PubMed ID: 31921893
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
    Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
    Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.
    Gao J; Collyer J; Wang M; Sun F; Xu F
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in Energy Metabolism Precede Alterations in Cardiac Structure and Function in Hypertrophic Preconditioning.
    Wu J; Lu J; Huang J; You J; Ding Z; Ma L; Dai F; Xu R; Li X; Yin P; Zhao G; Wang S; Yuan J; Yang X; Ge J; Zou Y
    Front Cardiovasc Med; 2020; 7():602100. PubMed ID: 33426002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.
    Du Y; Wang Y; Han X; Feng Z; Ma A
    Int Heart J; 2019 Nov; 60(6):1415-1420. PubMed ID: 31735781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    Cardiovasc Ultrasound; 2019 Oct; 17(1):21. PubMed ID: 31660989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction caused by m.2336T>C mutation with hypertrophic cardiomyopathy in cybrid cell lines.
    Li D; Sun Y; Zhuang Q; Song Y; Wu B; Jia Z; Pan H; Zhou H; Hu S; Zhang B; Qiu Y; Dai Y; Chen S; Xu X; Zhu X; Lin A; Huang W; Liu Z; Yan Q
    Mitochondrion; 2019 May; 46():313-320. PubMed ID: 30196098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA‑seq profiling of mRNA associated with hypertrophic cardiomyopathy.
    Ren CW; Liu JJ; Li JH; Li JW; Dai J; Lai YQ
    Mol Med Rep; 2016 Dec; 14(6):5573-5586. PubMed ID: 27840985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
    Tanaka T; Sohmiya K; Kawamura K
    J Mol Cell Cardiol; 1997 Jan; 29(1):121-7. PubMed ID: 9040027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.